Addressing the mental health crisis
As the nation deals with enforced isolation and increased social distancing measures to reduce the risk of spreading COVID-19, concerns have been raised about...
What does the pharma packaging and supply chain look like in 2021?
2020 was an immensely challenging year for the pharmaceutical industry. But it is also a year that will go down in history for being...
How the pandemic has changed one pharma company
Lee Gittings, Psoriasis Business Unit Director at LEO Pharma, answers Pf's questions and shares how the pandemic has changed one pharma company from the...
Streamlining biopharmaceutical data management in 2021
Graeme Dennis tells Pf why an overhaul in biopharmacuetical data management is necessary in 2021. Rarely, if ever, has the process of drug development garnered...
Increased footfall in pharmacies: Making the most of it
Involving pharmacists in the UK’s Covid-19 vaccine roll out programme not only recognises their importance, but also presents an opportunity to reignite conversations around...
The future of pharmaceutical manufacturing
When the World Health Organization (WHO) declared COVID-19 as a pandemic in March 2020, the pharmaceutical sector burst into action. By May, there were...
How pharma can enhance its digital presence
With COVID-19 accelerating online migration this year, the pharma industry has had to embrace online - and fast. Traditionally reliant on face-to-face communication and...
Reflections on regulatory information management in 2020
What has COVID-19 revealed in the way of regulatory information management (RIM) related shortcomings, and to what extent should pharmaceutical companies step up their...
Top tips for virtual medical education
Virtual solutions are one of the most effective communication channels to extend reach and frequency of engagement with customers. And following Covid-19 restrictions they...
How community pharmacy can create capacity in Secondary Care
It is a widely held belief that the pharmaceutical sector needs to understand the challenges faced by its colleagues in Acute Trusts. Secondary Care...
Latest articles
Government launches call for evidence to improve women’s health and care
The government is launching a 12-week call for evidence to better understand women’s experiences of the health and care system. Launching to coincide with International...
COVID-19 and key changes one year on
One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
FDA approves Roche’s Actemra/RoActemra for interstitial lung disease
Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Pharma marketing: UK vs US
Marketing medicines is a totally different ball game on each side of the pond.
The US is the only country, apart from New Zealand, which...
The role of women in the NHS in England
This International Women’s Day, NHS Digital has published an analysis of the role of women in the NHS in England. Women account for more than...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...